ArticlePharmaceutics2022

Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1.

Eun-Ji Choe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.